---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-23-000027"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2023-04-14T23:59:59+00:00"
generated_at: "2026-06-17T02:06:17.392751+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# GeneDx amends Executive Chairman agreement: reduced time, base salary $337,500

## Summary
- Jason Ryan's employment as Executive Chairman extended to Dec 31, 2023.
- For 2023, Ryan will work 50% time with base salary of $337,500.
- Target annual performance bonus for 2023 set at 100% of base salary.
- Amendment effective April 10, 2023; prior vesting End Date unchanged as Dec 31, 2022.

## SEC filing metadata
- accession: 0001818331-23-000027
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2023-04-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/0001818331-23-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833123000027/smfr-20230412.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-23-000027
- JSON: https://secwatch.observer/filing/0001818331-23-000027.json
- Plain text: https://secwatch.observer/filing/0001818331-23-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.